News

Cynata is pleased to inform investors that, following the engagement of Japan- based investor relations firm Finantec Co., Ltd. (as announced on the 9th of August 2017), a series of...

Read More

Q&A between Cynata CEO Dr Ross Macdonald and the respected and influential industry commentator Professor Paul Knoepfler of the UC Davis School of Medicine Read More...

Read More

Please listen to an interview with Dr Adrian Bloor, UK Chief Investigator in Cynata’s Phase 1 clinical trial in acute steroid resistant graft-versus-host disease (GvHD). [video width="1920" height="1080" mp4="http://cynata.com/wp-content/uploads/2017/05/Cynata-GvHD-Video.mp4"][/video]...

Read More